Professor David Cunningham and colleagues conducted a multivariate analysis of 154 patients receiving chemotherapy.
The research team found that baseline CA19-9 was an independent prognostic factor for overall survival.
|1-year overall survival was 46% with a baseline CA19-9 below the median value|
|British Journal of Cancer|
The 1-year overall survival was 19% and 46%, respectively, for patients with a baseline CA19-9 above or below the median value.
The research team concluded, “A fall of 20% in CA19-9 level from baseline was an independent prognostic factor for overall survival.”